DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Supriya Lifescience Limited — Appointment

NSE 58 min ago·6 Nov 2026, 7:48 am

Supriya Lifescience

Supriya Lifescience Limited has announced the appointment of Mr Mangesh Vaze as its Chief Operating Officer, effective November 6, 2026. This appointment is part of the company's strategy to strengthen its senior management team and drive future growth.

For investors, this move signals Supriya's commitment to operational efficiency and strategic expansion. Appointing a new COO often indicates a focus on streamlining business processes and executing long-term plans. It reassures stakeholders that the company is preparing for the next phase of its development.

Investors should watch for any future disclosures regarding Mr Vaze's specific responsibilities and background. This will help gauge the potential impact of his leadership on the company's operational performance and market position.